Department of Trauma and Orthopaedics, Leeds Teaching Hospitals, Leeds, UK.
Aix-Marseille University, APHM, CNRS, ISM, Sainte-Marguerite Hospital, Institute for Locomotion, Marseille, France.
Knee Surg Sports Traumatol Arthrosc. 2023 Jun;31(6):2060-2067. doi: 10.1007/s00167-023-07359-2. Epub 2023 Mar 10.
The application and interpretation of patient-reported outcome measures (PROM), following knee injuries, pathologies, and interventions, can be challenging. In recent years, the literature has been enriched with metrics to facilitate our understanding and interpretation of these outcome measures. Two commonly utilized tools include the minimal clinically important difference (MCID) and the patient acceptable symptoms state (PASS). These measures have demonstrated clinical value, however, they have often been under- or mis-reported. It is paramount to use them to understand the clinical significance of any statistically significant results. Still, it remains important to know their caveats and limitations. In this focused report on MCID and PASS, their definitions, methods of calculations, clinical relevance, interpretations, and limitations are reviewed and presented in a simple approach.
患者报告结局测量（PROM）在膝关节损伤、病变和干预后的应用和解释具有一定挑战性。近年来，文献中已经充实了许多指标，以帮助我们理解和解释这些结局测量。两个常用的工具包括最小临床重要差异（MCID）和患者可接受的症状状态（PASS）。这些测量方法具有临床价值，但常常被低估或误用。使用这些方法来理解任何统计学上显著结果的临床意义至关重要。不过，了解它们的注意事项和局限性也同样重要。在本报告中，我们重点探讨了 MCID 和 PASS，介绍了它们的定义、计算方法、临床相关性、解释和局限性，并采用了一种简单的方法进行呈现。
